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(1 to 22 months) spiral-CT scanning revealed distinct shrinkage of the
aneurysm, no graft migration or endoleak and patency of all revascularised
vessels, except one renal artery in two patients. No patient experienced any
temporary or permanent neurological deficit, and no dialysis was necessary.
ConclusionThe combined endovascular and open surgical approach is
feasible, without cross clamping of the aorta and with minimized ischemia
time for renal and visceral arteries, and seems to be an appropriate strategy
for patients with a thoraco-abdominal aortic aneurysm or dissection.
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Objective To present our experience using fenestrated and branched
endoluminal grafts for Para-anastomotic aneurysms (PAA) following prior
open aneurysm surgery, and after previous endovascular aneurysm repair
(EVAR) complicated by proximal type I endoleak.
Methods Fenestrated and/or branched EVAR was performed on
eleven patients. Indications included proximal type I endoleak after EVAR
and short infrarenal neck (n4), suprarenal aneurysm after open AAA
(n4), distal type I endoleak after endovascular TAA (n1), proximal
anastomotic aneurysm after open AAA (n1), and an aborted open AAA
repair due to bleeding around a short infrarenal neck.
ResultsThe operative target vessel success rate was 100% (28/28) with
aneurysm exclusion in all patients. Mean hospital stay was 6.0 days (range
2–12 days, SD 3.5 days). Thirty day mortality was 0%. All cause mortality
during 18 months mean follow-up (range 5–44 months, SD 16.7 months)
was 18% (2/11) with no deaths from aneurysm rupture. Cumulative visceral
branch patency was 96% (27/28) at 42 months. Average renal function
remained unchanged during the follow-up period.
Conclusions Our report highlights the potential of fenestrated and
branched technology to improve re-operative aortic surgical outcomes. The
unique difficulties of increased graft on graft friction hindering placement,
short working distance, and increased patient co-morbidities should be
recognized.
Medical Optimisation Can ReduceMorbidity andMortality Associated
with Elective Aortic Aneurysm Repair
Dawson J., Vig S., Choke E., Blundell J., Horne G., Downham C., Loftus I.,
Thompson M.M. Eur J Vasc Endovasc Surg 2006;33:99-103.
Objectives Patients with aortic aneurysms have significant comorbidi-
ties which influence outcome. Our practice includes comprehensive assess-
ment to identify comorbidities, allowing subsequent medical optimisation
prior to aneurysm repair. The aim of this study was to assess this process and
to identify any factors predictive of outcome.
Design Prospective observational study.
Materials Medical case notes of 200 patients referred with aortic
pathology.
Methods Data analysed included preoperative, perioperative and post-
operative factors. Multiple logistic regression analysis was performed to
identify predictors of outcome.
Results Following assessment 17 patients (8.5%) were found to be
unfit for intervention and 165 patients (82.5%) proceeded to aneurysm
repair. In this group assessment uncovered previously undiagnosed car-
diac, respiratory and renal comorbidity in 19%, 57% and 29% of patients
respectively. Multiple logistic regression analysis indicated that optimi-
sation by a renal physician reduced post-operative renal impairment (OR
0.12, 95% CI 0.03–0.45, P0.002) while optimisation by a cardiologist
reduced respiratory complications (OR 0.7, 95% CI 0.05–0.99,
P0.049). An abnormal echocardiogram was associated with pneumonia
(OR 6.9, 95% CI 1.6–29, P0.01) and death (OR 7.9, 95% CI 1.15–54,
P0.036).
Conclusion Pre-operative assessment identifies previously un-
diagnosed comorbidity in a significant proportion of patients. Sub-
sequent medical optimisation may reduce post-operative morbidity and
mortality.
Outcome of Ultrasound-guided Sclerotherapy for Varicose Veins: Me-
dium-term Results Assessed by Ultrasound Surveillance
Myers K.A., Jolley D., Clough A., Kirwan J. Eur J Vasc Endovasc Surg
2006;33:115-120.
Objective To estimate medium-term success after a technique for
ultrasound-guided sclerotherapy for superficial chronic venous disease.
DesignA prospective study in a single unit with ultrasound surveillance
after treatment.
Materials Results after 1189 treatment sessions for 807 venous saphe-
nous veins and related tributaries or non-saphenous tributaries in 489
patients.
Methods Univariate life table analysis determined primary and second-
ary success rates. Multivariate Cox regression analysis detected covariates
that affected outcome.
Results Primary and secondary success rates at 36 months for all veins
were 52.4% (95%CI 46–58%) and 76.8% (95%CI 71–82%). Cox regression
analysis for primary success for all veins showed significantly worse results for
saphenous veins compared to tributaries (HR 3.72 – 95%CI 1.9 to 7.3). Cox
regression for all saphenous veins showed independently worse results for
patients less than 40 years age (HR 2.16 – 95%CI 1.27–3.66), small
compared to great saphenous veins (HR 1.58 – 95%CI 1.11–2.24), veins
greater than 6mm diameter compared to smaller veins (HR 2.22 – 95%CI
1.40–3.50), liquid compared to foam sclerotherapy (HR 2.20 – 95%CI
1.28–3.78), lower volumes of sclerosant compared to volumes greater than
12 ml (HR 0.51 – 95%CI 0.33–0.81) and highly diluted compared to
concentrated sclerosant (HR 2.05 – 95%CI 1.21–3.46) with worse results
using highly diluted or undiluted 3% sclerosant compared to a 1.5% concen-
tration. There were no significant differences for primary success for saphe-
nous veins for date of procedure, sex, side, primary or recurrent varicose
veins, or commercial type of sclerosant.
Conclusions Ultrasound-guided sclerotherapy gives satisfactory re-
sults if it is accepted that treatment may need to be repeated to achieve
secondary success. Results provide a basis for further research to explore
factors that might affect outcome. Younger patients with larger diameter
saphenous veins may warrant alternative forms of treatment, particularly for
small saphenous reflux.
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